| Line 15: |
Line 15: |
| | | | |
| | ===Type I reactions=== | | ===Type I reactions=== |
| − | *Mediated by pharmacologically active substances from [[Mast cells - Anatomy & Physiology|mast cells]] and [[Basophils - Anatomy & Physiology|basophils]] | + | *Mediated by pharmacologically active substances from [[Mast Cells - WikiBlood|mast cells]] and [[Basophils - WikiBlood|basophils]] |
| | **Due to antigen-antibody (usually IgE) binding to receptors on those cells | | **Due to antigen-antibody (usually IgE) binding to receptors on those cells |
| | *Substances include histamine, serotonin, leukotriens, prostaglandins | | *Substances include histamine, serotonin, leukotriens, prostaglandins |
| Line 82: |
Line 82: |
| | *Microscopically: | | *Microscopically: |
| | **Hyperplastic superficial perivascular dermatitis | | **Hyperplastic superficial perivascular dermatitis |
| − | **Oedema, [[Mast cells - Anatomy & Physiology|mast cells]], [[Basophils - Anatomy & Physiology|basophils]], [[Eosinophils - Anatomy & Physiology|eosinophils]], [[Lymphocytes - Anatomy & Physiology|lymphocytes]], histiocytes | + | **Oedema, [[Mast Cells - WikiBlood|mast cells]], [[Basophils - WikiBlood|basophils]], [[Eosinophils - WikiBlood|eosinophils]], [[Lymphocytes - WikiBlood|lymphocytes]], histiocytes |
| | **Fibropruritic nodules covered by hyperplastic epidermis | | **Fibropruritic nodules covered by hyperplastic epidermis |
| | | | |
| Line 111: |
Line 111: |
| | **Mononuclear cells | | **Mononuclear cells |
| | **If chronic, epidermal hyperplasia | | **If chronic, epidermal hyperplasia |
| − | **May involve [[Eosinophils - Anatomy & Physiology|eosinophils]] | + | **May involve [[Eosinophils - WikiBlood|eosinophils]] |
| | | | |
| | ==Autoimmune reactions== | | ==Autoimmune reactions== |